Skip to main content
Log in

Inhibitory and Resistance-Modifying Potential of Plant-Based Alkaloids Against Methicillin-Resistant Staphylococcus aureus (MRSA)

  • Published:
Current Microbiology Aims and scope Submit manuscript

Abstract

Increased prevalence of methicillin-resistant Staphylococcus aureus (MRSA) has become a major threat to the health sector worldwide due to their virulence, limited therapeutic options and their distribution in both hospital and community settings. Discovery and development of new anti-MRSA agents as alternatives to the very few antibiotics left in the armamentarium are, thus, urgently required. Recently, an efflux mechanism in MRSA has been identified as one of the main contributors of resistance towards various structurally unrelated antibiotics. The potential of reserpine (a phytoalkaloid) as efflux pump inhibitor (EPI) against various microbes remains limited as the concentration needed for inhibition is toxic to humans. This study therefore aimed to evaluate 13 alkaloid compounds as potential inhibitory agents and/or potential EPIs against a panel of three MRSA isolates which not only differ in their susceptibility to vancomycin (amongst the last drugs available to treat serious MRSA infection), but also exhibited active efflux activity. Results indicated berberine’s moderate inhibitiory activity against two MRSA isolates scoring a minimum inhibitory concentration (MIC) value of 125 μg/ml. Notable efflux inhibitory activity (ranging from two- to eightfold Ethidium Bromide MIC reduction) meanwhile was detected from quinine, piperine and harmaline using reserpine as the positive control. Findings from this study support the opinion that a vast number of potential phytocompounds with pharmacological potential await discovery. Therapeutic application of these compounds, however, warrants further investigation to ascertain their pharmacodynamics and safety aspects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Alborzi A, Ba Pourabbas, Salehi H et al (2000) Prevalence and pattern of antibiotic sensitivity of methicillin-sensitive and methicillin-resistant Staphylococcus aureus in Shiraz-Iran. Iran J Med Sci 25:1–8

    Google Scholar 

  2. Bailie GR, Neal D (1998) Vancomycin ototoxicity and nephrotoxicity. A review. Med Toxicol Adverse Drug Exp 3:376–386

    Google Scholar 

  3. Bao B, Sun Q, Yao X et al (2005) Cytotoxic bisindole alkaloids from a marine sponge spongosorites sp. J Nat Prod 68:711–715

    Article  PubMed  CAS  Google Scholar 

  4. Biavasco F, Giovanetti E, Montanari MP et al (1991) Development of in-vitro resistance to glycopeptide antibiotics: assessment in staphylococci of different species. J Antimicrob Chemother 27:71–79

    Article  PubMed  CAS  Google Scholar 

  5. Birdsall TC, Kelly GS (1997) Berberine: therapeutic potential of an alkaloid found in several medicinal plants. Altern Med Rev 2:94–103

    Google Scholar 

  6. Centers for Disease Control, Prevention (2002) Staphylococcus aureus resistant to vancomycin-United States. Morb Mortal Wkly Rep MMWR 51:565–567

    Google Scholar 

  7. Cowan MM (1999) Plant products as antimicrobial agents. Clin Microbiol Rev 12:58–564

    Google Scholar 

  8. DeMarco CE, Cushing LA, Frempong-Manso E et al (2007) Efflux-related resistance to norfloxacin, dyes, and biocides in bloodstream isolates of Staphylococcus aureus. Antimicrob Agents Chemother 51:3235–3239

    Article  PubMed  CAS  Google Scholar 

  9. Elisabetsky E, Costa-Campos L (2006) The alkaloid alstonine: a review of its pharmacological properties. Evid Based Complement Altern Med 3:39–48

    Article  CAS  Google Scholar 

  10. Eloff JN (1998) A sensitive and quick microplate method to determine the minimal inhibitory concentration of plant extracts for bacteria. Planta Med 64:711–713

    Article  PubMed  CAS  Google Scholar 

  11. Foster TJ (2004) The Staphylococcus aureus “Superbug”. J Clin Invest 114:1693–1696

    PubMed  CAS  Google Scholar 

  12. Gibbons S (2004) Anti-staphylococcal plant natural products. Nat Prod Rep. 21:263–277

    Article  PubMed  CAS  Google Scholar 

  13. Gibbons S, Oluwatuyi M, Kaatz GW (2003) A novel inhibitor of multidrug efflux pumps in Staphylococcus aureus. J Antimicrob Chemother 51:13–17

    Article  PubMed  CAS  Google Scholar 

  14. Guz NR, Stermitz FR, Johnson JB et al (2001) Flavonolignan and flavone inhibitors of a Staphylococcus aureus multidrug resistance pumps: structure-activity relationships. J Med Chem 44:261–268

    Article  PubMed  CAS  Google Scholar 

  15. Hasse M (2002) Alkaloids: nature’s curse or blessing? Zurich. Wiley, VCH

    Google Scholar 

  16. Hiramatsu K, Hanaki H, Ino T et al (1997) Mehicillin resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 40:135–136

    Article  PubMed  CAS  Google Scholar 

  17. Khan IA, Mirza ZM, Kumar A et al (2006) Piperine, a phytochemical potentiator of ciprofloxacin against Staphylococcus aureus. Antimicrob Agents Chemother 50:810–812

    Article  PubMed  CAS  Google Scholar 

  18. Lomovskaya O, Watkins WJ (2001) Efflux pumps: their role in antibacterial drug discovery. Curr Med Chem 8:1699–1771

    PubMed  CAS  Google Scholar 

  19. Lukacs GL, Rotstein OD, Grinstein S (1991) Determinants of the phagosomal pH in macrophages. In situ assessment of vacuolar H(+)-ATPase activity, counterion conductance, and H + “leak”. J Biol Chem 266:2458–24540

    Google Scholar 

  20. Mashour NH, Lin GI, Frishman WH (1998) Herbal medicine for the treatment of cardiovascular disease - clinical considerations. Arch Intern Med 158:2225–2234

    Article  PubMed  CAS  Google Scholar 

  21. Mikos-Schild S (1998) MRSA-what every health care provider should know. Today’s Surg Nurse 20:20–24

    CAS  Google Scholar 

  22. National Committee for Clinical Laboratory Standards (2004) Performance standards for antimicrobial disk susceptibility tests, approved standard M100–S14. National Committee for Clinical Laboratory Standards, Villanova, Pa, pp 40–47

    Google Scholar 

  23. Oluwatuyi M, Kaatz GW, Gibbons S (2004) Antibacterial and resistance modifying activity of Rosmarinus officinalis. Phytochem 65:3249–3254

    Article  CAS  Google Scholar 

  24. Paulsen IT, Brown MH, Skurray RA (1996) Proton-dependent multidrug efflux systems. Microbiol Rev 60:60–575

    Google Scholar 

  25. Poole K (2005) Efflux-mediated antimicrobial resistance. J Antimicrob Chemother 56:20–51

    Article  PubMed  CAS  Google Scholar 

  26. Saiful AJ, Mastura M, Zarizal S et al (2006) Detection of methicillin-resistant Staphylococcus aureus using mecA/nuc genes and antibiotic susceptibility profile of Malaysian clinical isolates. World J Microbiol Biotechnol 22:1289–1294

    Article  CAS  Google Scholar 

  27. Saiful AJ, Mastura M, Zarizal S et al (2008) Efflux genes and active efflux activity detection in Malaysian clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA). J Basic Microbiol 48:245–251

    Article  PubMed  CAS  Google Scholar 

  28. Sharma P, Varma MVS, Chawla HPS et al (2005) In situ and in vivo efficacy of peroral absorption enhancers in rats and correlation to in vitro mechanistic studies. Il Farmaco 60:874–883

    Article  PubMed  CAS  Google Scholar 

  29. Sieradzki K, Tomasz A (1997) Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus. J Bacteriol 179:2557–2566

    PubMed  CAS  Google Scholar 

  30. Smigan P, Majernik A, Polak P et al (1995) The presence of H + and Na(+)-translocating ATPases in Methanobacterium thermoautotrophicum and their possible function under alkaline conditions. FEBS Lett 371:119–122

    Article  PubMed  CAS  Google Scholar 

  31. Spikes JD (1998) Photosentizing properties of quinine and synthetic antimalarials. J Photochem Photobiol B 42:1–11

    Article  PubMed  CAS  Google Scholar 

  32. Stavri M, Piddock LJ, Gibbons S (2007) Bacterial efflux pump inhibitors from natural sources. J Antimicrob Chemother 59:1247–1260

    Article  PubMed  CAS  Google Scholar 

  33. Tambyah PA, Habib AG, Toon-Mae BN et al (2003) Community-acquired methicillin-resistant Staphylococcus aureus infection in Singapore is usually “Healthcare associated”. Infect Cont Hosp Epidemiol 24:436–438

    Article  Google Scholar 

  34. Wieczorek H, Putzenlechner M, Zeiske W et al (1991) A vacuolar-type proton pump energizes K +/H + antiport in an animal plasma membrane. J Biol Chem 266:15340–15347

    PubMed  CAS  Google Scholar 

  35. Zloh M, Gibbons S (2004) Molecular similarity of MDR inhibitor. Int J Mol Sci 5:37–47

    Article  CAS  Google Scholar 

Download references

Acknowledgments

The authors acknowledge the funding support provided by the Forest Research Institute Malaysia (TGP - 40-300-40-3007), and Ministry of Science, Technology and Innovation, Malaysia (eIRPA - 30-300-40-3010), and thank Mrs. Hannan Abdul Wahab and Mr. Izanudin Zakaria for their technical assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mastura Mohtar.

Additional information

This study was supported by the FRIM’s Young Scientist Grant No. 40-300-40-3007 and the Intensified Research in Priority Areas (IRPA) Grant No. 30-300-40-3010 from the Ministry of Science, Technology and Innovation, Malaysia.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mohtar, M., Johari, S.A., Li, A.R. et al. Inhibitory and Resistance-Modifying Potential of Plant-Based Alkaloids Against Methicillin-Resistant Staphylococcus aureus (MRSA). Curr Microbiol 59, 181–186 (2009). https://doi.org/10.1007/s00284-009-9416-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00284-009-9416-9

Keywords

Navigation